FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

14061111000001100: Toctino 30mg capsules (Basilea Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
50100301000001111 Toctino 30mg capsules (Basilea Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
74274501000001118 Toctino 30mg capsules (Stiefel Laboratories (UK) Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Toctino 30mg capsules (Basilea Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Toctino 30mg capsules (Basilea Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Toctino 30mg capsules (Basilea Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Toctino 30mg capsules (Basilea Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Toctino 30mg capsules (Basilea Pharmaceuticals Ltd) Is a Alitretinoin 30mg capsules true Inferred relationship Existential restriction modifier
Toctino 30mg capsules (Basilea Pharmaceuticals Ltd) Has active ingredient Alitretinoin true Inferred relationship Existential restriction modifier
Toctino 30mg capsules (Basilea Pharmaceuticals Ltd) Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Toctino 30mg capsules (Basilea Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Toctino 30mg capsules (Basilea Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Toctino 30mg capsules (Basilea Pharmaceuticals Ltd) Has excipient Beeswax false Inferred relationship Existential restriction modifier
Toctino 30mg capsules (Basilea Pharmaceuticals Ltd) Is a Toctino true Inferred relationship Existential restriction modifier
Toctino 30mg capsules (Basilea Pharmaceuticals Ltd) Has specific active ingredient Alitretinoin true Inferred relationship Existential restriction modifier
Toctino 30mg capsules (Basilea Pharmaceuticals Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Toctino 30mg capsules (Basilea Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Toctino 30mg capsules (Basilea Pharmaceuticals Ltd) Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Toctino 30mg capsules (Basilea Pharmaceuticals Ltd) 30 capsule 3 x 10 capsules Is pack of False Toctino 30mg capsules (Basilea Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Toctino 30mg capsules (Basilea Pharmaceuticals Ltd) 30 capsule 3 x 10 capsules Has AMP True Toctino 30mg capsules (Basilea Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start